2012 SPONSORSHIP PROGRAM
| INTRODUCTION |
WHO WE ARE
The Canadian Consortium for the Investigation of Cannabinoids (CCIC) is a federally registered Canadian nonprofit organization of basic and clinical researchers and health care professionals established to promote evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents. On behalf of its Members, the Consortium will:
- Advance basic and clinical research on the therapeutic applications of endocannabinoid and cannabinoid agents
- Inform and advise healthcare providers about the endocannabinoid system and cannabinoid therapeutic options
- Create a networking forum for Canadian and international researchers investigating endocannabinoids and cannabinoids
WHAT DO WE DO
2011 has been another successful year so far for the CCIC! With the hard work of our Board and Staff, and with the generous support of our sponsors, we have been able to achieve the following milestones:
- Increase CCIC membership
- Attend and develop booth presence at major healthcare forums, conferences and events worldwide
- Continue to provide online versions of both accredited cannabinoid educational programs, ACE II and ACE III
- Organize and implement a successful accredited symposium “Cannabinoids in Clinical Practice” at the ICRS Conference 2011
- Provide trainee conference travel support and graduate student summer research support to qualified applicants
- Initiate and continue small study research projects
- Expand outreach and maintain correspondence with private, professional and governmental organizations
WE NEED YOU
More education and research, greater networking, and deeper outreach are essential building blocks towards continued success. In this regard, the CCIC looks to our sponsors to help support further research and educational activities for the benefit of both parties and for the patients who ultimately are the target of all our work.
The CCIC’s mission is achieved by means of vital partnerships with our Sponsors. The CCIC is funded through both restricted and unrestricted sponsorship and grants from various stakeholders both in the private and public sectors. Financial support from our sponsors allows the CCIC to undertake initiatives and reach goals set out by the organization. In that regard, the CCIC has several exciting projects underway for 2012 and has designed a Sponsorship/Grant Program that will allow your organization to benefit from its involvement.
The CCIC follows Canadian Rx&D guidelines and subscribes to the CMA Code of Conduct for interactions with the pharmaceutical industry. Our policies are available on our website. The CCIC will not endorse any single product.
| SUMMARY REVIEW OF 2011 ACCOMPLISHMENTS |
CCIC Accredited Cannabinoid Education Programs (ACE)
The CCIC continues to promote its highly visible national education program series, both in live lecture and online format for healthcare practitioners. The ACE program series is designed to provide a forum to exchange ideas and concerns, to educate and to stimulate interest in cannabinoids as a viable and effective medical option.
In 2011, the CCIC marketed the on-line version of the ACE II and ACE III programs to reach a wider audience.
- - ACE II – “A Case-Based Learning Program” introduces 3 leaning scenarios using three case-based approaches:
Case 1 (Introducing cannabinoids in clinical practice), Case 2 (Monitoring patients using cannabinoids) and Case 3 (Medical cannabis: Access & authorization). - - ACE III – “Synergies- Cannabinoids and Opioids in Clinical Therapeutics” expanded the series and looks into the possible synergies of cannabinoids and opioids following appropriate patient screening and selection.
The online versions of both of these programs are available at www.vitalcme.com.
CCIC “Cannabinoids and Spasticity” Round Table Educational Series
The CCIC engaged with Bayer Healthcare to organize a series of expert round table discussions in Toronto and Montreal in the spring of 2011 that focused on the clinical evidence of cannabinoids in the treatment of spasticity. These events were designed to raise awareness of the use of medicinal cannabinoids, to review updates in research and clinical trial results, and to discuss how to prescribe cannabinoids for the treatment of spasticity in patients with multiple sclerosis.
CCIC Biomedical Visualization project “A Magic Journey”
The CCIC, in collaboration with the University of Toronto Biomedical Communications department, developed a simulated visual 3D animation of the pathway of cannabinoids from entry to metabolism. This narrated video is a useful cannabinoid education tool and is available for viewing on our ccic.net website.
CCIC Symposium “Cannabinoids in Clinical Practice, Challenges and Opportunities” at ICRS 2011
A very exciting initiative that the CCIC undertook in 2011 was the organization of an accredited clinical symposium at the 2011 Annual Meeting of the International Cannabinoid Research Society (ICRS) in Chicago, Illinois, July 8th 2011.
This half day symposium attracted over 60 scientists, clinicians and industry representatives from around the world. The focus of this event was on current endocannabinoid and cannabinoid research and views on the future of this dynamic field of research and patient care. It included featured talks by internationally renowned cannabinoid experts and was fully accredited by the University California San Francisco (UCSF).
CCIC presence at major scientific congresses
As part of our ongoing mandate to network, the CCIC secured strategic booth presence at the following congresses in 2010:
- The Canadian Pain Society Annual Meeting, Niagara Falls, Ontario, April 13-16, 2011
- The American Psychiatric Association Annual Scientific Meeting, Honolulu, Hawaii, May 13-16, 2011
- The Consortium for Multiple Sclerosis Centers, Montreal, Quebec May 30- June 2 2011
- International Cannabinoid Research Society 2011 Annual Meeting, Chicago, Illinois, July 5-10, 2011
- Family Medicine Forum, Montreal, Quebec, Nov 3-5, 2011
The CCIC has also been involved in formal presentations to the Colorado State Board of Health and The American Society of Addiction Medicine.
CCIC sponsored research activities
Research is another main theme for the CCIC. In 2011 we made progress on a number of initiatives:
- Student Awards - In 2011 the CCIC continued its annual student funding competition program to support research activities that aligned with the vision and objectives of the CCIC. A CCIC appointed committee established criteria and reviewed applications. In total 5 Trainee conference support travel grants and 1 Graduate student research grant were awarded.
- Research Seed Funding – The CCIC continues to provide seed funding and financial support for approved research studies.
- Research studies – An ongoing commitment to the advancement of basic and clinical research on the therapeutic applications of cannabinoids has led the CCIC to be involved in the development of clinical studies in 2011; public details are available upon request.
CCIC outreach activities
Outreach remains important, and throughout the year the CCIC maintained correspondence with Health Canada, responding to proposed regulatory changes to the Medical Marijuana Access Regulations (MMAR) and the Canadian Medical Association (CMA) regarding its policy on Medical Marijuana; in 2011 we also worked closely with Canadian Health Magazine on patient interest stories. The CCIC continues to liaise with important international and local societies such as the International Association of Cannabinoid Medicine (IACM), the International Cannabinoid Research Society (ICRS), the International Association for the Study of Pain (IASP) and the Quebec Pain Research Network (QPRN).
| CCIC 2012 PROJECT INITIATIVES |
Canada has been an excellent training ground for the CCIC to develop clinical experience with cannabinoids, as well as to develop our cannabinoid research and education experience, but we recognize that educational needs are similar in the USA and Europe where the topic of medical cannabinoids continues to attract interest from the public, health care professionals, policy makers and patients.
Therefore, as we look into 2012, the CCIC’s continued focus is to expand its educational expertise and knowledge to regions outside of Canada where cannabinoid medications are available and where knowledge gaps in cannabinoid education have been identified.
While we will continue to work closely with physicians in Canada with our ACE series programs and other educational initiatives, we have identified other places where health care providers, patients and organizations may benefit from the quality, independent and expert educational programs on cannabinoids and endocannabioids that the CCIC can provide. Sponsorship for any or all program(s) is requested.
CCIC-organized “Cannabinoids and Pain Update 2012:
the state of the art, the state of the science;
Official Satellite Symposium of the 14th World Congress on Pain”
Milan, Italy, Aug 2012(*)
The CCIC will host a one-day Official Satellite Symposium of the 14th World Congress on Pain, the biannual meeting of the International Association for the Study of Pain, in Milan, Italy August 25th 2012. This is a full-day symposium focusing on up-to-date cannabinoid research from around the world. It will feature talks by internationally renowned clinical and basic science cannabinoid experts. The symposium will also include a cannabinoid research poster presentation session and an Industry session discussing the latest updates on cannabinoid research.
CCIC ACE Series California, USA ( with USCF, Fall 2012 ) (*)
Working in partnership with our colleagues at the University California San Francisco (UCSF), the CCIC’s next foray into US education will be the organization of an Accredited Clinical Education Program series to run in California in the autumn of 2012.
The program is intended to be an accredited cannabinoid education (ACE) lecture program with open discussion, paid registration, delivered on site at major hospital or clinic locations in cannabinoid relevant locations. The set program will feature 3 expert speakers and will run approximately 3 hours.
CCIC presence at major scientific congresses 2012 (*)
The CCIC will secure strategic booth presence at the following congresses:
- Patients Out of Time Conference, Tucson Arizona, USA April 26-28 2012
- The Canadian Pain Society Annual Meeting, Whistler BC, Canada May 23-26, 2012
- Canadian Association of Physical Medicine and Rehabilitation, Toronto,ON,Canada June 20-23 2012
- International Association for the Study of Pain, World Congress on Pain, Milan, Italy Aug 27-31 2012
- Family Medicine Forum, Toronto, ON, Canada, November 15-17, 2012
Under Consideration:
- American Society of Clinical Oncology, Chicago, Illinois, June 1-5, 2012
- Canadian Psychiatric Association 62st Annual Conference, Montreal, Canada, Sept 27-29th, 2012
- American Society for Addiction Medicine, Washington DC April 19-22 2012
CCIC sponsored research activities
The CCIC will continue to expand our research activities for 2012. These include:
- Additional student research grants and travel awards
- Seed funding for selected research projects
- Investigator initiated studies (*)
CCIC “Cannabinoids and Spasticity” Round Table Educational Series (Western Canada)
The CCIC will expand the 2011 series of expert round table discussions for our colleagues in Western Canada.
CCIC Round Table on Medical Cannabis Research Priorities
This unique event will bring together a group of clinical and scientific experts representing various disciplines and all regions of Canada to determine research priorities surrounding the medical use of cannabis.
The objectives of this event will be to:
- Identify key research priorities surrounding the use of cannabis for medicinal purposes,
- Establish criteria for measuring the safety of the use of cannabis for medicinal purposes,
- Discuss monitoring and data collection strategies,
- Form research collaborations on the safety and monitoring of cannabis use for medicinal purposes.
(*) Available as project specific sponsorship/grant opportunity
| ONGOING WORK |
CCIC Website
The CCIC launched a comprehensive new website in 2009 containing research information, data and accredited educational components for all healthcare stakeholders and the general public. CCIC.net is updated regularly and is becoming the definitive portal on cannabinoid research and education.
CCIC Monthly Newsletter
The CCIC distributes a monthly newsletter to all CCIC sponsors and members. The CCIC newsletter updates all stakeholders, healthcare practitioners and the general public on current news and events, as it pertains to cannabinoid research and education.
CCIC Membership
Click here for the Membership Update (pdf)
| 2012 SPONSORSHIP OPTIONS - How you can get involved |
I. CCIC organizational sponsorship
This general funding goes to help support CCIC organizational overhead, networking and outreach. Sponsors will be recognized appropriately on CCIC materials, including website and events.
- Flagship sponsor (only 1 available) > $50,000
- Premium sponsor ($25,000 – $49,000)
- Corporate sponsor ($15,000- $24,000)
- Partnering sponsor ($10,000-$14,000)
- Contributing sponsor ($1,000- $9,000 )
II. CCIC Program/Project Funding
Project (Target) sponsorship/grants (available only for selected CCIC managed projects) Sponsors will receive recognition based on project sponsored and amount of funding provided. Please contact CCIC to get more information on specifics of funding opportunity.
The following 2012 CCIC programs are available for funding:
- ACE programs (Canada, USA, Other)
- IASP Satellite Symposium
- Conference Funding
III. Recognition/Awards Sponsorship
Support for achievement and excellence in the field. The following awards are available to fund.
- Student research support ($5000 per student)
- Trainee conference travel ($1000 per award)
- Clinical research recognition (Annual award and gift)
- Pre Clinical research recognition (Annual award and gift)
IV. In-Kind Sponsorship
In kind contributions are welcome and recognized by the CCIC. In-kind contributions may include donated equipment, services, other items or facilities necessary to directly implement a project or program that would otherwise have to be purchased if they were not donated by the contributing organization or elicited from other sources. These contributions are specified as other than monetary. Sponsors will be recognized by the CCIC.
V. Affiliated Partners Program
This program focuses on developing links between the CCIC and other professional societies that share common goals. Professional societies and similar nonprofit membership organizations can gain access to the CCIC through our Affiliated Partners Program. This includes an exchange of mutually beneficial services, links but no exchange of funds. Partners participating in this program will be recognized by the CCIC.